DARATUMUMAB IN MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL CLINICAL PRACTICE IN CATALONIA

被引：0
|
作者：
Moreno, David Fernando [1 ]
Gomez-Hernando, Marta [1 ]
Clapes, Victoria [2 ]
Soler, Juan Alfons [3 ]
Gonzalez-Montes, Yolanda [4 ]
Gironella, Mercedes [5 ]
Motllo, Cristina [6 ]
Granell, Miquel [7 ]
Abella, Eugenia [8 ]
Garcia-Pintos, Marta [9 ]
Garcia-Guinon, Antoni [10 ]
Cabezudo, Elena [2 ]
Rosinol, Laura [1 ]
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] ICO Duran i Reynals Hosp Llobregat, Barcelona, Spain
[3] Hosp Parc Tauli Sabadell, Barcelona, Spain
[4] ICO Josep Trueta Girona, Girona, Spain
[5] Hosp Vall dHebron Barcelona, Barcelona, Spain
[6] Hosp St Joan Deu Manresa, Barcelona, Spain
[7] Hosp St Pau Barcelona, Barcelona, Spain
[8] Hosp del Mar Barcelona, Barcelona, Spain
[9] Consorci Sanitari Terrassa, Barcelona, Spain
[10] Hosp Arnau de Vilanova Lleida, Lleida, Spain
来源：
HAEMATOLOGICA | 2020年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-007
引用
收藏
页码：138 / 139
页数：2
相关论文
共 50 条
  • [1] Clinical Efficacy of Daratumumab Monotherapy in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma
    Usmani, Saad
    Weiss, Brendan
    Bahlis, Nizar J.
    Belch, Andrew
    Lonial, Sagar
    Lokhorst, Henk
    Voorhees, Peter M.
    Richardson, Paul G.
    Sasser, A. Kate
    Axel, Amy
    Feng, Huaibao
    Uhlar, Clarissa
    Wang, Jianping
    Khan, Imran
    Ahmadi, Tahamtan
    Nahi, Hareth
    BLOOD, 2015, 126 (23)
  • [2] Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma
    Usmani, Saad Z.
    Weiss, Brendan M.
    Plesner, Torben
    Bahlis, Nizar J.
    Belch, Andrew
    Lonial, Sagar
    Lokhorst, Henk M.
    Voorhees, Peter M.
    Richardson, Paul G.
    Chari, Ajai
    Sasser, A. Kate
    Axel, Amy
    Feng, Huaibao
    Uhlar, Clarissa M.
    Wang, Jianping
    Khan, Imran
    Ahmadi, Tahamtan
    Nahi, Hareth
    BLOOD, 2016, 128 (01) : 37 - 44
  • [3] Brief report: Clinical experiences after emergency use of daratumumab monotherapy for relapsed or refractory multiple myeloma in real practice
    Park, Sung-Soo
    Eom, Hyeon-Seok
    Kim, Jin Seok
    Koh, Youngil
    Choi, Chul Won
    Lee, Je-Jung
    Kim, Kihyun
    Suh, Cheolwon
    Lee, Jae Hoon
    Min, Chang-Ki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (01) : 92 - 95
  • [4] Daratumumab monotherapy in heavily pretreated Asians patients with relapsed and refractory multiple myeloma
    Yoon, Sung-Soo
    Byun, Ja Min
    Park, Hyunkyung
    Lee, Ji Yun
    Koh, Youngil
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E155 - E156
  • [5] Efficacy of daratumumab monotherapy in real-world heavily pretreated patients with relapsed or refractory multiple myeloma
    Salomon-Perzynski, Aleksander
    Walter-Croneck, Adam
    Usnarska-Zubkiewicz, Lidia
    Dytfeld, Dominik
    Zielinska, Patrycja
    Wojciechowska, Malgorzata
    Holojda, Jadwiga
    Robak, Pawel
    Pasternak, Anna
    Knopinska-Posluszny, Wanda
    Hawrylecka, Dorota
    Wojtowicz, Marcin
    Szeremet, Agnieszka
    Osowiecki, Michal
    Mordak-Domagala, Monika
    Zaucha, Jan Maciej
    Giannopoulos, Krzysztof
    Warzocha, Krzysztof
    Jamroziak, Krzysztof
    ADVANCES IN MEDICAL SCIENCES, 2019, 64 (02): : 349 - 355
  • [6] Real-world outcomes of daratumumab monotherapy in relapsed/refractory myeloma
    Maouche, N.
    Leary, H.
    Collings, F.
    Tseu, B.
    Djebbari, F.
    Vallance, G.
    Ramasamy, K.
    Kothari, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 125 - 125
  • [7] Daratumumab Monotherapy in Heavily Pretreated Asian Patients With Relapsed and Refractory Multiple Myeloma: A Real-world Experience
    Byun, Ja Min
    Yoon, Sung-Soo
    Koh, Youngil
    Kim, Inho
    Jo, Jaemin
    Park, Hyunkyung
    Lee, Jeong-Ok
    Lee, Jiyun
    ANTICANCER RESEARCH, 2019, 39 (09) : 5165 - 5170
  • [8] Daratumumab monotherapy for relapsed/refractory multiple myeloma, focussed on clinical trial-unfit patients and subsequent therapy
    Park, Sung-Soo
    Byun, Ja Min
    Yoon, Sung-Soo
    Kim, Kihyun
    Jung, Sung-Hoon
    Lee, Je-Jung
    Min, Chang-Ki
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (01) : 101 - 112
  • [9] A new monoclonal antibody, Daratumumab monotherapy in the treatment of refractory or relapsed multiple myeloma
    Richez, Valentine
    Legros, Laurence
    Leleu, Xavier
    HEMATOLOGIE, 2015, 21 (05): : 260 - 261
  • [10] Daratumumab triplet therapies in patients with relapsed or refractory multiple myeloma: A "real world" experience
    Fucci, Ludovica
    Gensini, Lorenzo
    Coppetelli, Ugo
    La Barbera, Elettra Ortu
    Gentile, Martina
    Fiori, Luciano
    Perrone, Salvatore
    Cimino, Giuseppe
    LEUKEMIA RESEARCH REPORTS, 2022, 17
12345